作者:Chuangxing Guo、Xinjun Hou、Liming Dong、Eleanor Dagostino、Samantha Greasley、RoseAnn Ferre、Joseph Marakovits、M. Catherine Johnson、David Matthews、Barbara Mroczkowski、Hans Parge、Todd VanArsdale、Ian Popoff、Joseph Piraino、Stephen Margosiak、James Thomson、Gerrit Los、Brion W. Murray
DOI:10.1016/j.bmcl.2009.08.034
日期:2009.10
Pin1 is a member of the cis-trans peptidyl-prolyl isomerase family with potential anti-cancer therapeutic value. Here we report structure-based de novo design and optimization of novel Pin1 inhibitors. Without a viable lead from internal screenings, we designed a series of novel Pin1 inhibitors by interrogating and exploring a protein crystal structure of Pin1. The ligand efficiency of the initial concept molecule was optimized with integrated SBDD and parallel chemistry approaches, resulting in a more attractive lead series. (C) 2009 Elsevier Ltd. All rights reserved.